Your browser doesn't support javascript.
loading
Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas.
Rühl, Julia; Citterio, Carmen; Engelmann, Christine; Haigh, Tracey; Dzionek, Andrzej; Dreyer, Johannes; Khanna, Rajiv; Taylor, Graham S; Wilson, Joanna B; Leung, Carol S; Münz, Christian.
Afiliação
  • Rühl J; Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Citterio C; Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Engelmann C; Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Haigh T; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Birmingham, United Kingdom.
  • Dzionek A; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.
  • Dreyer J; Institute for Pathology, Unfallkrankenhaus Berlin, Berlin, Germany.
  • Khanna R; QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Tumour Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Taylor GS; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Birmingham, United Kingdom.
  • Wilson JB; College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Leung CS; University of Oxford, Nuffield Department of Medicine, Ludwig Institute for Cancer Research, Oxford, United Kingdom.
  • Münz C; Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
J Clin Invest ; 129(5): 2071-2087, 2019 05 01.
Article em En | MEDLINE | ID: mdl-31042161

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Vacinas Anticâncer / Antígenos Nucleares do Vírus Epstein-Barr / Infecções por Vírus Epstein-Barr / Linfoma Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Vacinas Anticâncer / Antígenos Nucleares do Vírus Epstein-Barr / Infecções por Vírus Epstein-Barr / Linfoma Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article